Vasomotor symptoms (VMS) are common complaints in 80% of postmenopausal women, having a great impact on their global quality of life. Several therapeutic options are available for treating these patients. Hormonal replacement therapy is the current therapeutic standard for VMS, but it is associated with well-known potential risks. Fezolinetant...
-
2020 (v1)PublicationUploaded on: February 4, 2024
-
2019 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2020 (v1)Publication
No description
Uploaded on: February 4, 2024 -
2020 (v1)Publication
Tisotumab vedotin (TV) is a humanized antibody-drug conjugate (ADC) directed against tissue factor, a protein involved in signaling pathways related to angiogenesis, cell adhesion, motility and survival. It has been reported that tissue factor is aberrantly expressed by many types of solid tumors and it is associated with negative oncological...
Uploaded on: February 14, 2024 -
2021 (v1)Publication
Background: Ovarian carcinoma (OC) is one of the most widespread tumors in the world and is characterized by low survival rates. Objective: To determine whether the levonorgestrel-releasing intrauterine system (LNG-IUS) can prevent OC. Search strategy: The literature until December 2020 were systematically reviewed according to the PRISMA...
Uploaded on: April 14, 2023 -
2020 (v1)Publication
In this paper, we present beam pattern tests performed on the SWIPE multi-mode bolometric detector pixel assembly. A 20-mm-aperture horn is coupled to a large detector absorber (10 mm diameter) with a TES sensor located on the side. The pixel assembly has been tested at the bolometer base temperature of 340 mK, inside a custom cryogenic test...
Uploaded on: April 14, 2023